New Delhi -°C
Today in New Delhi, India

Sep 28, 2020-Monday
-°C

Humidity
-

Wind
-

Select Country
Select city
ADVERTISEMENT
Home / World News / Pfizer announces deal with Canada for experimental Covid-19 vaccine

Pfizer announces deal with Canada for experimental Covid-19 vaccine

Deliveries of the BNT162 mRNA-based vaccine candidate are planned over the course of 2021, subject to clinical success and Health Canada approval, the two companies said in a statement. They did not reveal financial details.

world Updated: Aug 05, 2020 19:34 IST
Reuters | Posted by Arpan Rai
Reuters | Posted by Arpan Rai
Ottawa
A man walks past a sign outside Pfizer Headquarters in the Manhattan borough of New York City.
A man walks past a sign outside Pfizer Headquarters in the Manhattan borough of New York City.(REUTERS)

Pharmaceutical giant Pfizer Inc and German biotech firm BioNTech SE on Wednesday said they had signed a deal to supply Canada with an experimental coronavirus vaccine.

Deliveries of the BNT162 mRNA-based vaccine candidate are planned over the course of 2021, subject to clinical success and Health Canada approval, the two companies said in a statement. They did not reveal financial details.

Separately, the Canadian government said it would make an announcement on the next steps in procuring vaccines at 10 a.m. ET (1400 GMT) on Wednesday.

There are no approved vaccines for the illness caused by the new coronavirus, but 19 vaccines are being tested in humans around the world.

tags
ht epaper

Sign In to continue reading